DR. Brian Adam Davis, M.D. is a sports medicine physical medicine rehabilitation in Las Vegas, NV with 32 years of experience. The provider is a physician who specializes in Sports Medicine is responsible for continuous care related to the enhancement of health and fitness as well as the prevention of injury and illness. The specialist possesses knowledge and experience in the promotion of wellness and the prevention of injury from many areas of medicine such as exercise physiology, biomechanics, nutrition, psychology, physical rehabilitation, epidemiology, physical evaluation and injuries. It is the goal of a Sports Medicine specialist to improve the healthcare of the individual engaged in physical exercise. DR. Brian Adam Davis, M.D. NPI is 1760463830. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Graduation Year:1992
The provider's business location address is:
9280 W SUNSET RD STE 426
LAS VEGAS, NV
ZIP 89148-862
Phone: (702) 688-8110
The NPI 1760463830 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
- Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance (HCPCS:20611)
- Administration of influenza virus vaccine (HCPCS:G0008)
The enumeration date for this NPI number is 11/7/2005 and was last updated on 2/11/2021.